EBioMedicine

期刊简介：The effective translation of insights gained from biomedical research into improved human health is a global priority. To this end, Elsevier has looked to the leadership of its two leading brands, Cell and The Lancet, to guide the launch of a new comprehensive, online-only open access Elsevier journal, EBioMedicine, focused on forming a community that spans this interface and creates a valuable opportunity for dialogue and collaboration between their respective audiences.

【译文】将生物医学研究获得的见解有效转化为改善人类健康的全球优先事项。为此，Elsevier寻求其两个领先品牌Cell和The Lancet的领导，以指导推出一本全新的、仅在线的开放获取Elsevier期刊EBioMedicine，专注于形成一个跨越这一界面的社区，并为各自受众之间的对话和合作创造宝贵的机会。